UASt regulatory sequences drive expression of an inverted repeat.
Expression of trioGD9531 using Scer\GAL4sev.EP, and in the presence of Dcr-2Scer\UAS.cDa, results in growth of R7 axons beyond the M6 layer of the medulla.
Adults expressing trioGD9531 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in a weak flyer phenotype or adult/pharate lethality.
Expression under the control of Scer\GAL4pnr-MD237 results in extra bristles on the notum in 0% or 10-20% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in loss of bristles on the notum in 0% or 90-100% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 0% or 10-20% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Scer\GAL4elav.PU, trioGD9531 has abnormal neuroanatomy | larval stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has decreased size | larval stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has abnormal neuroanatomy | embryonic stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU, trioGD9531 has abnormal neuroanatomy | embryonic stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has abnormal neuroanatomy | larval stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU, trioGD9531 has decreased size | larval stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of abnormal neuroanatomy | embryonic stage phenotype of E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of abnormal neuroanatomy | larval stage phenotype of E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of abnormal neuroanatomy | embryonic stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of abnormal neuroanatomy | larval stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of increased size | larval stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of increased size | larval stage phenotype of E2f1i2/E2f107172
trioGD9531/Scer\GAL4GMR.PFa is a non-suppressor of visible | adult stage phenotype of Scer\GAL4GMR.PFa, egrUAS.cMa
Scer\GAL4elav.PU, trioGD9531 has embryonic/larval neuromuscular junction | larval stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has NMJ bouton | larval stage | decreased number phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has axon | embryonic stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU, trioGD9531 has connective | embryonic stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU, trioGD9531 has commissure | embryonic stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU, trioGD9531 has axon | embryonic stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has connective | embryonic stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has commissure | embryonic stage phenotype, suppressible by mir-33KO
Scer\GAL4elav.PU, trioGD9531 has embryonic/larval neuromuscular junction | larval stage phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU, trioGD9531 has NMJ bouton | larval stage | decreased number phenotype, suppressible by E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of axon | embryonic stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of connective | embryonic stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of commissure | embryonic stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of embryonic/larval neuromuscular junction | larval stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of NMJ bouton | increased number | larval stage phenotype of mir-33KO
Scer\GAL4elav.PU/trioGD9531 is a suppressor of commissure | embryonic stage phenotype of E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of connective | embryonic stage phenotype of E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of axon | embryonic stage phenotype of E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of NMJ bouton | increased number | larval stage phenotype of E2f1i2/E2f107172
Scer\GAL4elav.PU/trioGD9531 is a suppressor of embryonic/larval neuromuscular junction | larval stage phenotype of E2f1i2/E2f107172
trioGD9531/Scer\GAL4GMR.PFa is a non-suppressor of eye phenotype of Scer\GAL4GMR.PFa, egrUAS.cMa
The dot-like small eye phenotype characteristic for flies expressing egrScer\UAS.cMa under the control of Scer\GAL4GMR.PFa cannot be suppressed by co-expression of trioGD9531 RNAi.